Influence of Genetic Polymorphisms in CYP2C8 and ABCB1 on the Mobilization Ability and Toxicity of Paclitaxel

被引：0
|
作者：
Lozano, Maria L. [1 ]
Nino, Elkin A. [1 ]
Isabel Anton, Ana [2 ]
Padilla, Jose [2 ]
Rivera, Jose [2 ]
Jose Cerezo, Juan [2 ]
Castilla-Llorente, Cristina [1 ]
Garcia, Vicente [2 ]
机构：
[1] Hosp Gen Univ Morales Meseguer, Hematol & Clin Oncol Unit, Murcia, Spain
[2] Univ Murcia, Ctr Reg Hemodonac, Murcia, Spain
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1730 / 1730
页数：1
相关论文
共 50 条
  • [1] Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxel
    Henningsson, A
    Marsh, S
    Loos, WJ
    Karlsson, MO
    Garsa, A
    Mross, K
    Mielke, S
    Viganò, L
    Locatelli, A
    Verweij, J
    Sparreboom, A
    McLeod, HL
    CLINICAL CANCER RESEARCH, 2005, 11 (22) : 8097 - 8104
  • [2] Effect of genetic variants in CYP2C8, CYP3A4, CYP3A5, and ABCB1 on paclitaxel pharmacokinetics.
    Sparreboom, A
    Marsh, S
    Henningsson, A
    Karlsson, MO
    Garsa, A
    Loos, WJ
    Verweij, J
    McLeod, HL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 139S - 139S
  • [3] Influence of CYP3A5, CYP2C8 and ABCB1 Polymorphisms on Tacrolimus-Induced Nephrotoxicity in Liver Transplant Recipients
    Shi, Yunying
    Tang, Jiangtao
    Zhang, Junlong
    An, Yunfei
    Liao, Yun
    Li, Yi
    Wang, Lanlan
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 696 - 696
  • [4] INFLUENCE OF CYP3A5, CYP2C8 AND ABCB1 POLYMORPHISMS ON TACROLIMUS-INDUCED NEPHROTOXICITY IN LIVER TRANSPLANT RECIPIENTS
    Shi, Yunying
    Tang, Jiangtao
    Zhang, Junlong
    An, Yunfei
    Liao, Yun
    Li, Yi
    Tao, Ye
    Wang, Lanlan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 122 - 122
  • [5] CYP2C8 haplotype structures and influence of genetic polymorphisms on pharmacokinetics of paclitaxel in a Japanese population
    Katori, N.
    Saito, Y.
    Nakajima, Y.
    Yoshitani, T.
    Kim, S. -R.
    Fukushima-Uesaka, H.
    Kaniwa, N.
    Kamatani, N.
    Minami, H.
    Yoshida, T.
    Yamamoto, N.
    Tamura, T.
    Saijo, N.
    Sawada, J.
    PROCEEDINGS OF THE 8TH CONGRESS OF THE EUROPEAN ASSOCIATION FOR CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2007, : 157 - +
  • [6] Genetic polymorphisms of human CYP2C8 and their effects on metabolism of anticancer drug: Paclitaxel
    Dai, D
    Blaisdell, JA
    Chanas, B
    Ghanavem, BL
    Goldstein, JA
    FASEB JOURNAL, 2000, 14 (08): : A1338 - A1338
  • [7] Genetic polymorphisms of CYP2C8 in Japanese population
    Nakajima, M
    Fujiki, Y
    Noda, K
    Ohtsuka, H
    Ohkuni, H
    Kyo, S
    Inoue, M
    Kuroiwa, Y
    Yokoi, T
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (06) : 687 - 690
  • [8] Genetic Polymorphisms of CYP2C8 in the Czech Republic
    Pechandova, Kristina
    Buzkova, Helena
    Matouskova, Olga
    Perlik, Frantisek
    Slanar, Ondrej
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2012, 16 (07) : 812 - 816
  • [9] Neurological toxicity after phenytoin infusion in a pediatric patient with epilepsy: influence of CYP2C9, CYP2C19 and ABCB1 genetic polymorphisms
    Dorado, P.
    Lopez-Torres, E.
    Penas-LLedo, Em
    Martinez-Anton, J.
    LLerena, A.
    PHARMACOGENOMICS JOURNAL, 2013, 13 (04): : 359 - 361
  • [10] Neurological toxicity after phenytoin infusion in a pediatric patient with epilepsy: influence of CYP2C9, CYP2C19 and ABCB1 genetic polymorphisms
    P Dorado
    E López-Torres
    E M Peñas-LLedó
    J Martínez-Antón
    A LLerena
    The Pharmacogenomics Journal, 2013, 13 : 359 - 361
12345